HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:391
|
作者
YOSHIMURA, M
YASUE, H
MORITA, E
SAKAINO, N
JOUGASAKI, M
KUROSE, M
MUKOYAMA, M
SAITO, Y
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[3] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE HEART FAILURE; NATRIURESIS;
D O I
10.1161/01.CIR.84.4.1581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study was designed to examine the hemodynamic, renal, and hormonal effects of brain natriuretic peptide (BNP) infusion in patients with congestive heart failure (CHF) and in control subjects. Methods and Results. We infused synthetic human BNP at a rate of 0.1-mu-g/kg/min. BNP infusion decreased pulmonary capillary wedge pressure (control, from 5 +/- 1 to 2 +/- 1 mm Hg, p < 0.01; CHF, from 21 +/- 3 to 14 +/- 4 mm Hg, p < 0.05) and systemic vascular resistance (control, from 1,264 +/- 75 to 934 +/- 52 dyne.sec.cm-5; CHF, from 2,485 +/- 379 to 1,771 +/- 195 dyne.sec.cm-5; p < 0.01, respectively) and increased stroke volume index (control, from 49.9 +/- 2.7 to 51.5 +/- 2.3 ml/m2, p = NS; CHF, from 25.6 +/- 3.8 to 32.0 +/- 3.9 ml/m2, p < 0.01). BNP infusion significantly increased urine volume (control, from 2.3 +/- 0.7 to 7.5 +/- 1.9 ml/min; CHF, from 0.8 +/- 0.2 to 5.3 +/- 1.0 ml/min; p < 0.01, respectively), excretion of sodium (control, from 79.2 +/- 21.6 to 332.8 +/- 70.9-mu-Eq/min; CHF, from 77.4 +/- 20.8 to 753.5 +/- 108.0-mu-Eq/min; p < 0.01, respectively), and excretion of chloride (control, from 72.5 +/- 18.4 to 256.0 +/- 43.3-mu-Eq/min; CHF, from 74.0 +/- 19.6 to 708.8 +/- 103.3-mu-Eq/min; p < 0.01, respectively). Urinary excretion of sodium and of chloride in response to BNP infusion was higher in patients with CHF than in control subjects (p < 0.01, respectively). BNP infusion increased the levels of plasma atrial natriuretic peptide (control, from 65 +/- 11 to 84 +/- 14 pg/ml; CHF, from 262 +/- 65 to 301 +/- 62 pg/ml; p < 0.05, respectively) and decreased plasma aldosterone concentrations in both groups (control, from 43.3 +/- 12.1 to 27.3 +/- 7.1 pg/ml; CHF, from 91.1 +/- 34.3 to 66.3 +/- 27.2 pg/ml; p < 0.05, respectively). Conclusions. We conclude that BNP infusion improves left ventricular function in patients with CHF by vasodilation and prominent natriuretic action.
引用
收藏
页码:1581 / 1588
页数:8
相关论文
共 50 条
  • [41] HEMODYNAMIC EVALUATION OF IBOPAMINE IN PATIENTS WITH REFRACTORY CONGESTIVE-HEART-FAILURE
    HUMAR, F
    MORGERA, T
    MARAS, P
    CAMERINI, F
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-1 (2A): : 360 - 362
  • [42] INCREASED PLASMA-LEVELS OF ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    PETTERSSON, A
    HEDNER, J
    HEDNER, T
    HELD, P
    SWEDBERG, K
    TOWLE, AC
    EUROPEAN HEART JOURNAL, 1986, 7 (08) : 693 - 696
  • [43] Augmenting renal function in experimental congestive heart failure by brain natriuretic peptide and Lasix
    Cataliotti, A
    Chen, HH
    Boerrigter, G
    Costello-Boerrigter, LC
    Tsuruda, T
    Malatino, LS
    Burnett, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 193A - 194A
  • [44] INCREASED PLASMA-LEVELS AND BLUNTED EFFECTS OF BRAIN NATRIURETIC PEPTIDE IN RATS WITH CONGESTIVE-HEART-FAILURE
    HOFFMAN, A
    GROSSMAN, E
    KEISER, HR
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (07) : 597 - 601
  • [45] Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
    Koglin, J
    Pehlivanli, S
    Schwaiblmair, M
    Vogeser, M
    Cremer, P
    von Scheidt, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 1934 - 1941
  • [46] Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea
    Carmona-Bernal, C
    Quintana-Gallego, E
    Villa-Gil, M
    Sánchez-Armengol, A
    Martínez-Martínez, A
    Capote, F
    CHEST, 2005, 127 (05) : 1667 - 1673
  • [47] Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure
    Tsutamoto, T
    Wada, A
    Maeda, K
    Hisanaga, T
    Fukai, D
    Maeda, Y
    Ohnishi, M
    Mabuchi, N
    Kinoshita, M
    AMERICAN HEART JOURNAL, 1997, 134 (05) : 910 - 916
  • [48] ACUTE HEMODYNAMIC AND HORMONAL EFFECTS OF CENTRAL VERSUS PERIPHERAL SYMPATHETIC INHIBITION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    OLIVARI, MT
    LEVINE, TB
    COHN, JN
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (05) : 973 - 977
  • [49] ANTIDIURETIC-HORMONE AND ATRIAL-NATRIURETIC-PEPTIDE IN CONGESTIVE-HEART-FAILURE
    FYHRQUIST, F
    TIKKANEN, I
    ACTA MEDICA SCANDINAVICA, 1986, : 55 - 58
  • [50] HEMODYNAMIC, RENAL AND ENDOCRINE EFFECTS OF ATRIAL NATRIURETIC PEPTIDE INFUSION IN SEVERE HEART-FAILURE
    MOLINA, CR
    FOWLER, MB
    MCCRORY, S
    PETERSON, C
    MYERS, BD
    SCHROEDER, JS
    MURAD, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (01) : 175 - 186